Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreser ...
An international team of researchers led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the ...
Gene mutations have consequences both good and bad—from resistance to conditions like diabetes to susceptibility to certain ...
She says a mysterious pain kept her in and out of the hospital as a child. "It really kept me from enjoying-- doing the ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported third quarter results and business highlights for the quarter ended September ...
A next generation Snap Cartridge, part of the Gazelleâ„¢ S-10B Hb Variant Test Multipack, will simplify sample preparation so ...
CASGEVY is a CRISPR/Cas9 gene-edited cell therapy indicated for the treatment of patients aged 12 years and older with (1) ...
Sickle Cell patients can't accept just any type of blood. It must have specific CEK antigens. Experts have found that 1 in 3 ...
Scientists have identified new gene faults and evolutionary patterns contributing to testicular cancer. Their findings offer profound insights into the development of the disease and into potential ...
“The need for effective therapeutic options for patients with sickle cell disease has become even more urgent due ... Fulcrum uses proprietary technology to identify drug targets that can modulate ...
A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...